"Over the 14 months between December of 2013 and February 2015, the Company successfully executed three CLOs that term financed approximately $1.1 billion of collateral at a weighted average cost of LIBOR + 1.74% and weighted average leverage of 77.24%. RSO's weighted average annual yield on the retained equity in these CLOs will be between 17% and 19%."
that is the bulk of their lending. how you missed that news is beyond me.
Wow, I just did a rough estimate on that potential windfall... over 9K in afterhour trading...maybe.
Yes another on my shopping list along with CVX
I've only seen this company register shares as they sell them. Putting another 150 million worth out there ready to go killed this offering.
We have owned some forever, since we bought Texaco many years before it became part of CVX, but it keeps falling and the dividend is so enticing that I can hardly pass up buying more, but I hate to try to catch a falling knife.
Sentiment: Strong Buy
I don't recall the delisting criteria but PTN is on whatever the American Stock Exchange is called these days (bought by the NYSE, I think). So there may not be a $1 minimum.
If there is, it takes about a year of sub-$1 on the Nasdaq to be has to be under $1 for some time and then there is an automatic 6 month extension.
The "drawback" of costing more ... is that really a drawback for the patient? If Otrexup is covered by insurance, then the patient doesn't really pay more, and least not the full amount more ... maybe the insurance company, but not the patient?
Implied within your ''hmmmmm…..''
Do you believe that pennies and deep-green have been manipulating this stock thru shorting?
Is that a correct assumption on my part?